NCT06081530View on ClinicalTrials.gov

A Study in Healthy Men to Test How Well Different Doses of BI 3802876 Are Tolerated

PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

October 27, 2023

Primary Completion Date

March 20, 2025

Study Completion Date

March 20, 2025

Conditions
Healthy
Interventions
DRUG

BI 3802876

BI 3802876

DRUG

Placebo matching BI 3802876

Placebo matching BI 3802876

Trial Locations (1)

2650

SGS Life Science Services - Clinical Research, Edegem

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06081530 - A Study in Healthy Men to Test How Well Different Doses of BI 3802876 Are Tolerated | Biotech Hunter | Biotech Hunter